baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Journey Medical Corp/ US48115J1097 /

2024-05-20 9:59:58 PM	Chg. -0.03	Volume	Bid-	Ask-	High	Low
3.44USD	-0.86%	450 Turnover: 1,566.39	-Bid Size: -	-Ask Size: -	3.55	3.44

GlobeNewswire 05-15 Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire 05-15 Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthc...

GlobeNewswire 05-13 Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highli...

GlobeNewswire 05-07 Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024

GlobeNewswire 05-01 Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer

GlobeNewswire 04-25 Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024

GlobeNewswire 03-28 Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights

GlobeNewswire 03-21 Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

GlobeNewswire 03-18 Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the...

GlobeNewswire 03-15 Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024

GlobeNewswire 03-13 Journey Medical Corporation to Participate in the 36th Annual ROTH Conference

GlobeNewswire 03-11 Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the...

GlobeNewswire 02-14 Ocuphire Pharma Strengthens Leadership Team with Key Appointments

GlobeNewswire 01-05 Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea

GlobeNewswire 01-02 Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million

GlobeNewswire 2023-12-06 Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-...

GlobeNewswire 2023-11-14 Fortress Biotech Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

GlobeNewswire 2023-11-07 Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate Highli...

GlobeNewswire 2023-10-31 Journey Medical Corporation to Announce Third Quarter 2023 Financial Results on November 7, 2023

GlobeNewswire 2023-10-20 Journey Medical Corporation Announces Data from Bioavailability Study of DFD-29 (Minocycline Hydroch...

GlobeNewswire 2023-09-06 Journey Medical Corporation Enters into an Exclusive License Agreement with Maruho Co., Ltd. for Qbr...

GlobeNewswire 2022-03-28 Fortress Biotech Reports Record 2021 Financial Results and Recent Corporate Highlights

GlobeNewswire 2022-03-23 Journey Medical Corporation Reports Full-Year 2021 Financial Results and Recent Corporate Highlights

GlobeNewswire 2022-03-18 Journey Medical Corporation to Release Year End 2021 Financial Results and Provide Corporate Update ...

GlobeNewswire 2022-03-17 Journey Medical Corporation Announces First Patient Dosed in Phase 3 Clinical Trial Evaluating DFD-2...

Journey Medical Corp/ US48115J1097 /

If you wish to receive reply to your feedback, please provide your email address.